Skip to content

The effect of left breast radiotherapy on the heart.

Evaluation of the relationship between mean heart dose in left breast cancer radiation therapy with Pro-BNP and Troponin values and left ventricular systolic function based on LVEF and GLS values in echocardiography.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210822052256N2
Enrollment
37
Registered
2022-03-17
Start date
2022-01-15
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure. Systolic (congestive) heart failure

Interventions

Intervention group: Women with left breast cancer who are treated with conventional 3D or hypofractionated radiation therapy with a dose of 50 Gy in 25 fractions or 42.5 Gy in 16 fractions..

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with left breast cancer over the age of 18 that have undergone left breast radiation therapy at Omid Hospital Have not received chemotherapy or just received the TC (taxane-cyclophosphamide) chemotherapy regimen

Exclusion criteria

Exclusion criteria: Patients under 18 years old Patients with end stage or metastatic malignancy Patients with two synchronous cancers Patients with a history of heart failure with LVEF=50% or a history of valvular heart disease or advanced congenital heart disease or proven coronary artery disease Patients with a history of chest radiation therapy Pregnant patients with breast cancer Patients receives or have received of anthracyclines and trastuzumab

Design outcomes

Primary

MeasureTime frame
Heart mean dose in radiation therapy for left breast cancer. Timepoint: Before and 6 months after left breast radiotherapy. Method of measurement: Dose volume histogram.

Secondary

MeasureTime frame
Troponin. Timepoint: Before and just after left breast radiotherapy. Method of measurement: Laboratory test.;Brain natriuretic peptide. Timepoint: Before and just after left breast radiotherapy. Method of measurement: Laboratory test.;Left ventricle ejection fraction. Timepoint: Before and just after left breast radiotherapy. Method of measurement: Echocardiography.;Global longitudinal strain. Timepoint: Before and just after left breast radiotherapy. Method of measurement: Echocardiography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Akhavan

Esfahan University of Medical Sciences

aliakhavan@med.mui.ac.ir+98 31 3235 0210

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026